Amid EU green pass row, some European countries recognise Covishield

At least eight European countries, namely Austria, Estonia, Germany, Greece, Ireland, Netherlands, Slovenia and Spain have recognised Covishield

Covaxin, Covishield
Photo: Bloomberg
BS Web Team
2 min read Last Updated : Jul 05 2021 | 8:29 AM IST
While India’s two Coronavirus (Covid-19) vaccines -- Covishield and Covaxin -- await approval from the European Medicines Agency and the World Health Organisation, respectively, some European countries have gone ahead and recognised the former for the purpose of travel. 

At least 8 European countries, namely Austria, Estonia, Germany, Greece, Ireland, Netherlands, Slovenia and Spain have recognised Covishield, according to an HT report. This means that when these countries lift the travel ban on India, Indians vaccinated with Covishield will be allowed to travel to these countries. Apart from these 8 countries, Finland and Latvia have also reportedly approved Covishield, while Estonia has approved both Covishield and Covaxin. Switzerland and Iceland have also accepted Covishield for travel purposes.

There were concerns in India after the EU introduced the green pass, a travel pass among European countries for those vaccinated with either of four vaccines, namely Comirnaty of Pfizer/BioNTech, Moderna, Vaxzervria by AstraZeneca-Oxford and, Johnson & Johnson’s Janssen. 

While Covishield is the Indian counterpart of AstraZeneca-Oxford developed Vaxzervria, it wasn’t mentioned in the list for EU green pass. Adar Poonawalla, CEO of Serum Institute of India, the producer of Covishield, has said he has taken up the issue at the highest levels and hoped to resolve the matter soon. 

The EU green pass will allow for seamless travel within the EU’s 27 member states. Countries are expected to not place additional travel restrictions such as mandatory quarantine on those travelling with the green pass, which is essentially a proof of vaccination. 

India has urged EU member nations to individually recognise Covishield and Covaxin and treat vaccinated Indians at par with those vaccinated in EU countries. This request comes with a diplomatic push that if Covishield and Covaxin are not recognised in EU countries, then people with EU vaccines will also not get quarantine exemption in India.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus Vaccine

Next Story